A phase III development program is ongoing and has already enrolled more than 600 patients with plaque psoriasis, said Blauvelt. New Drug Candidate for Alopecia Areata Patients with severe ...

Wearing a hat won't make you bald in and of itself, Thacker says.

“Our continued success in Japan—a highly advanced clinical environment—demonstrates the growing recognition of XTRAC’s benefits for patients with vitiligo, psoriasis, alopecia ...

Nail changes can reveal hidden health issues long before other symptoms appear. Here's what to watch for and why it matters.

Patent protection for ZORYVE cream 0.3% extends until at least 2037. ZORYVE cream 0.3% is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in adult and ...

Psoriasis, Alopecia Areata and Atopic Dermatitis. The study, titled “Excimer Laser Penetrates Deeper into Hair Follicles and Activates More Melanocyte Lineage Cells than Excimer Light ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

Q4 2024 Earnings Call Transcript March 27, 2025 STRATA Skin Sciences, Inc. misses on earnings expectations. Reported EPS is $ ...

psoriasis, alopecia areata, and atopic dermatitis. The study reveals that the Excimer Laser, due to its high repetition rate and high dose, achieves deeper penetration into hair follicles ...

Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This ...